Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab
Clinical trial NCT06304545 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06304545
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2026-08-16
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.